Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study.

@article{Heinzl2002EffectsOI,
  title={Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa in children with cystic fibrosis: a pilot study.},
  author={Bernd Heinzl and Ernst Eber and B{\'e}atrice Oberwaldner and Gertrude Haas and Maximilian S. Zach},
  journal={Pediatric pulmonology},
  year={2002},
  volume={33 1},
  pages={32-7}
}
Inhaled antibiotics are an established treatment for chronic Pseudomonas aeruginosa (PA) infection in patients with cystic fibrosis (CF). However, inhaled antibiotics might also have prophylactic potential to delay acquisition of PA in early stages of the disease. From 1986-1999, all CF patients at this center who experienced defined risk situations for acquisition of PA (28 patients) received inhaled gentamicin (80 mg BID for those < 12 months; 120 mg BID for those > 12 months) for a minimum… CONTINUE READING